CMS has approvedLouisiana’s plan to supply hepatitis C treatments under a subscription-based payment model, the agency announced June 27. Under the model, a subsidiary of Gilead Sciences, Asegua ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results